<DOC>
	<DOCNO>NCT00624481</DOCNO>
	<brief_summary>This study conduct compare effect increase nasal teriparatide dose percent change Bone Mineral Density ( BMD ) lumbar spine 24 week therapy postmenopausal woman low bone mineral density .</brief_summary>
	<brief_title>Study Evaluate Effect Intranasal Teriparatide Bone Mineral Density Postmenopausal Women With Low BMD</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Bone Diseases , Metabolic</mesh_term>
	<mesh_term>Teriparatide</mesh_term>
	<criteria>Postmenopausal Female patient 89 year , inclusive ; BMI ≤ 35 kg/m2 , inclusive ; In good health , determine medical history physical examination , well normal 12lead ECG vital sign ; Females nonpregnant , nonlactating , either postmenopausal least 1 year , surgically sterile ( include tubal ligation , hysterectomy ) least 3 month , 30 day follow Study Completion willing use approve method contraception ; Have minimum two evaluable nonfractured lumbar vertebra . Have low bone mineral density define Tscore ≤ 2.0 determine DXA scan either lumbar spine ( L1L4 ) total hip Serious Medical Condition History diseases affect bone metabolism postmenopausal osteoporosis Paget 's disease , secondary cause osteoporosis , hypoparathyroidism , hyperparathyroidism Have history cancer within past 5 year , except basal cell carcinoma Have hypocalcemia hypercalcemia cause recent history kidney stone preexist hypercalciuria ; Have use mostly commonly prescribe osteoporosis medication within 3 month start investigational product , 1 month time within 6 month prior start investigational product .</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>89 Years</maximum_age>
	<verification_date>March 2008</verification_date>
	<keyword>osteoporosis</keyword>
	<keyword>osteopenia</keyword>
	<keyword>bone mineral density</keyword>
	<keyword>teriparatide</keyword>
</DOC>